You are here: Industry Insights > API

News List

Sandoz outlines European antibiotic manufacturing expansion cphi-online
May 20, 2021
Novartis generics and biosimilars division will invest €150 million during the next 3-5 years at its Kundl, Austria and Palafolls, Spain sites while phasing out production of oral APIs at Les Franqueses site
Colorcon Adds New Containment Suite in Its Global Headquarters contractpharma
May 20, 2021
Colorcon, a leader in the development and supply of film coating systems and excipients, has expanded its technical service capabilities with a new Containment Suite located in its Global Headquarters in Harleysville, PA, USA.
CMOs should invest in biologic API manufacturing capabilities, says GlobalData europeanpharmaceuticalreview
May 14, 2021
Research shows the complexity and number of biologics is increasing, as is the frequency at which their active pharmaceutical ingredient (API) production is outsourced.
Applying Agile methodologies in CDMOs expresspharma
May 14, 2021
In order to truly help biotech and pharma companies in their journey from drug development to commercialisation, contract development and manufacturing organisations (CDMOs) have begun to incorporate the latest innovations in all aspects of their ...
Growing opportunities in API manufacturing as innovative biologic approvals increase: GlobalData expresspharma
May 13, 2021
The US Food and Drug Administration (FDA) approved more biologic new molecular entities (NMEs) in 2020 than in any other year in the previous decade, while at the same time, sponsors increased the outsourcing of these biologics’ active pharmaceutical ...
Angelini Fine Chemicals Invests in Flow Chemistry & Micro-Reaction Technology contractpharma
May 13, 2021
A confluence of factors is driving the need for a paradigm shift in pharmaceutical manufacturing strategies in order to accelerate R&D pipeline to market.
Carbogen Amcis signs co-funding pact worth over CHF 15 million to expand Swiss site expresspharma
April 30, 2021
Carbogen Amcis will produce exclusively for the signatory customer a complex highly potent drug component for a commercial antibody-drug-conjugate API.
Collaboration to encourage US adoption of continuous manufacturing europeanpharmaceuticalreview
April 14, 2021
USP and Phlow have built a new laboratory to develop test methods and standards to facilitate broader adoption of continuous manufacturing in the US.
Solara Active Pharma and Aurore Life Sciences merge to create pure-play API/CRAMs company expresspharma
April 12, 2021
The Board of Directors of Solara Active Pharma Sciences accepted the recommendations of the Committee of Independent Directors and Audit Committee and approved the amalgamation of Aurore, Empyrean and Hydra with Solara.
Centre bans exports of remdesivir until COVID situation gets better expresspharma
April 12, 2021
In view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre said the export of the antiviral injection and its Active Pharmaceutical Ingredients (API) has been banned till the situation improves.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page